Global Artificial Vital Organs Market

Artificial Vital Organs Comprehensive Study by Type (Artificial Liver, Artificial Heart, Artificial Pancreas, Artificial Kidney, Artificial Lungs), Application (Hospitals, Clinics, Research Centers, Others) Players and Region - Global Market Outlook to 2030

Artificial Vital Organs Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.64%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Artificial Vital Organs Market Scope
In the era of deformities, it’s no more the time to be disappointed for the inabilities as technology has taken steps ahead for making disabled the better by working in the field of artificial vital organs. Hence given the market to grow the variants of fields with the well-being of human-made machines and body organs for the proper functioning of disabled or inoperative parts.

According to AMA, the Global Artificial Vital Organs market is expected to see growth rate of 8.64%

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Artificial Vital Organs market throughout the predicted period.

Edwards Lifesciences Corporation (United States), Abbott Diabetes Care,Inc. (United Kingdom), Baxter International,Inc. (United States), Asahi Kasei Medical Co (United Kingdom), Ekso Bionics (United States), Jarvik Heart (United States), Ottobock Healthcare GmbH (Germany), Berlin Heart GmbH (Germany), Boston Scientific Corporation (United States), F Hoffman-La Roche Ltd. (Switzerland) and Gambro AB (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Lifenet Health (United States), Thoratec Corporation (Canada) and World heart Corporation (United States).

Segmentation Overview
The study have segmented the market of Global Artificial Vital Organs market by Type (Artificial Liver, Artificial Heart, Artificial Pancreas, Artificial Kidney and Artificial Lungs), by Application (Hospitals, Clinics, Research Centers and Others) and Region with country level break-up.

On the basis of geography, the market of Artificial Vital Organs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing Organ Failure

Market Growth Drivers:
Advancement in Technology of Biomedical, Rising Rate of Organ Failures Due To Major Disorders, High Occurrence Rate of Road Accidents and Injuries Leading To Organ Losses and Lack of Donors For Organs

Challenges:
Lack of Surgical Expertise

Restraints:
Chances of Machine Failures and Its Significance and Lack of Skilled Operatives to Carry Out the Procedures

Opportunities:
Holding and Developing a Skillful Workforce and Improving Income Levels & Rising Awareness Could Push Demand In Emerging Economies

Market Leaders and their Expansionary Development Strategies
In December 2022, Jhonson and Jhonson one of the world diversified healthcare product company announced it has completed Acquistion of Abiombed Inc.
In August 2022,U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced a new prize competition from the Kidney Innovation Accelerator (KidneyX) that seeks to further the development of a fully functional bioartificial kidney.


Key Target Audience
Manufacturer, Providers, Supplier and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Artificial Liver
  • Artificial Heart
  • Artificial Pancreas
  • Artificial Kidney
  • Artificial Lungs
By Application
  • Hospitals
  • Clinics
  • Research Centers
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Advancement in Technology of Biomedical
      • 3.2.2. Rising Rate of Organ Failures Due To Major Disorders
      • 3.2.3. High Occurrence Rate of Road Accidents and Injuries Leading To Organ Losses
      • 3.2.4. Lack of Donors For Organs
    • 3.3. Market Challenges
      • 3.3.1. Lack of Surgical Expertise
    • 3.4. Market Trends
      • 3.4.1. Increasing Organ Failure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Vital Organs, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Artificial Vital Organs (Value)
      • 5.2.1. Global Artificial Vital Organs by: Type (Value)
        • 5.2.1.1. Artificial Liver
        • 5.2.1.2. Artificial Heart
        • 5.2.1.3. Artificial Pancreas
        • 5.2.1.4. Artificial Kidney
        • 5.2.1.5. Artificial Lungs
      • 5.2.2. Global Artificial Vital Organs by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Research Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Artificial Vital Organs Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Artificial Vital Organs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Edwards Lifesciences Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Diabetes Care,Inc. (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Baxter International,Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asahi Kasei Medical Co (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ekso Bionics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Jarvik Heart (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ottobock Healthcare GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Berlin Heart GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boston Scientific Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F Hoffman-La Roche Ltd. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Gambro AB (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Artificial Vital Organs Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Artificial Vital Organs (Value)
      • 7.2.1. Global Artificial Vital Organs by: Type (Value)
        • 7.2.1.1. Artificial Liver
        • 7.2.1.2. Artificial Heart
        • 7.2.1.3. Artificial Pancreas
        • 7.2.1.4. Artificial Kidney
        • 7.2.1.5. Artificial Lungs
      • 7.2.2. Global Artificial Vital Organs by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Research Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Artificial Vital Organs Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Vital Organs: by Type(USD Billion)
  • Table 2. Artificial Vital Organs Artificial Liver , by Region USD Billion (2018-2023)
  • Table 3. Artificial Vital Organs Artificial Heart , by Region USD Billion (2018-2023)
  • Table 4. Artificial Vital Organs Artificial Pancreas , by Region USD Billion (2018-2023)
  • Table 5. Artificial Vital Organs Artificial Kidney , by Region USD Billion (2018-2023)
  • Table 6. Artificial Vital Organs Artificial Lungs , by Region USD Billion (2018-2023)
  • Table 7. Artificial Vital Organs: by Application(USD Billion)
  • Table 8. Artificial Vital Organs Hospitals , by Region USD Billion (2018-2023)
  • Table 9. Artificial Vital Organs Clinics , by Region USD Billion (2018-2023)
  • Table 10. Artificial Vital Organs Research Centers , by Region USD Billion (2018-2023)
  • Table 11. Artificial Vital Organs Others , by Region USD Billion (2018-2023)
  • Table 12. South America Artificial Vital Organs, by Country USD Billion (2018-2023)
  • Table 13. South America Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 14. South America Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 15. Brazil Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 16. Brazil Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 17. Argentina Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 18. Argentina Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 19. Rest of South America Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 20. Rest of South America Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 21. Asia Pacific Artificial Vital Organs, by Country USD Billion (2018-2023)
  • Table 22. Asia Pacific Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 23. Asia Pacific Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 24. China Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 25. China Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 26. Japan Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 27. Japan Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 28. India Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 29. India Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 30. South Korea Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 31. South Korea Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 32. Taiwan Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 33. Taiwan Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 34. Australia Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 35. Australia Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 36. Rest of Asia-Pacific Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 37. Rest of Asia-Pacific Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 38. Europe Artificial Vital Organs, by Country USD Billion (2018-2023)
  • Table 39. Europe Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 40. Europe Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 41. Germany Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 42. Germany Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 43. France Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 44. France Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 45. Italy Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 46. Italy Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 47. United Kingdom Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 48. United Kingdom Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 49. Netherlands Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 50. Netherlands Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 51. Rest of Europe Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 52. Rest of Europe Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 53. MEA Artificial Vital Organs, by Country USD Billion (2018-2023)
  • Table 54. MEA Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 55. MEA Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 56. Middle East Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 57. Middle East Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 58. Africa Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 59. Africa Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 60. North America Artificial Vital Organs, by Country USD Billion (2018-2023)
  • Table 61. North America Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 62. North America Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 63. United States Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 64. United States Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 65. Canada Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 66. Canada Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 67. Mexico Artificial Vital Organs, by Type USD Billion (2018-2023)
  • Table 68. Mexico Artificial Vital Organs, by Application USD Billion (2018-2023)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Artificial Vital Organs: by Type(USD Billion)
  • Table 81. Artificial Vital Organs Artificial Liver , by Region USD Billion (2025-2030)
  • Table 82. Artificial Vital Organs Artificial Heart , by Region USD Billion (2025-2030)
  • Table 83. Artificial Vital Organs Artificial Pancreas , by Region USD Billion (2025-2030)
  • Table 84. Artificial Vital Organs Artificial Kidney , by Region USD Billion (2025-2030)
  • Table 85. Artificial Vital Organs Artificial Lungs , by Region USD Billion (2025-2030)
  • Table 86. Artificial Vital Organs: by Application(USD Billion)
  • Table 87. Artificial Vital Organs Hospitals , by Region USD Billion (2025-2030)
  • Table 88. Artificial Vital Organs Clinics , by Region USD Billion (2025-2030)
  • Table 89. Artificial Vital Organs Research Centers , by Region USD Billion (2025-2030)
  • Table 90. Artificial Vital Organs Others , by Region USD Billion (2025-2030)
  • Table 91. South America Artificial Vital Organs, by Country USD Billion (2025-2030)
  • Table 92. South America Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 93. South America Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 94. Brazil Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 95. Brazil Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 96. Argentina Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 97. Argentina Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 98. Rest of South America Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 99. Rest of South America Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 100. Asia Pacific Artificial Vital Organs, by Country USD Billion (2025-2030)
  • Table 101. Asia Pacific Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 102. Asia Pacific Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 103. China Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 104. China Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 105. Japan Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 106. Japan Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 107. India Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 108. India Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 109. South Korea Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 110. South Korea Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 111. Taiwan Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 112. Taiwan Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 113. Australia Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 114. Australia Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 115. Rest of Asia-Pacific Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 116. Rest of Asia-Pacific Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 117. Europe Artificial Vital Organs, by Country USD Billion (2025-2030)
  • Table 118. Europe Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 119. Europe Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 120. Germany Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 121. Germany Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 122. France Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 123. France Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 124. Italy Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 125. Italy Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 126. United Kingdom Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 127. United Kingdom Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 128. Netherlands Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 129. Netherlands Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 130. Rest of Europe Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 131. Rest of Europe Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 132. MEA Artificial Vital Organs, by Country USD Billion (2025-2030)
  • Table 133. MEA Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 134. MEA Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 135. Middle East Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 136. Middle East Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 137. Africa Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 138. Africa Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 139. North America Artificial Vital Organs, by Country USD Billion (2025-2030)
  • Table 140. North America Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 141. North America Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 142. United States Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 143. United States Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 144. Canada Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 145. Canada Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 146. Mexico Artificial Vital Organs, by Type USD Billion (2025-2030)
  • Table 147. Mexico Artificial Vital Organs, by Application USD Billion (2025-2030)
  • Table 148. Research Programs/Design for This Report
  • Table 149. Key Data Information from Secondary Sources
  • Table 150. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Vital Organs: by Type USD Billion (2018-2023)
  • Figure 5. Global Artificial Vital Organs: by Application USD Billion (2018-2023)
  • Figure 6. South America Artificial Vital Organs Share (%), by Country
  • Figure 7. Asia Pacific Artificial Vital Organs Share (%), by Country
  • Figure 8. Europe Artificial Vital Organs Share (%), by Country
  • Figure 9. MEA Artificial Vital Organs Share (%), by Country
  • Figure 10. North America Artificial Vital Organs Share (%), by Country
  • Figure 11. Global Artificial Vital Organs share by Players 2023 (%)
  • Figure 12. Global Artificial Vital Organs share by Players (Top 3) 2023(%)
  • Figure 13. Global Artificial Vital Organs share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2023
  • Figure 17. Abbott Diabetes Care,Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Diabetes Care,Inc. (United Kingdom) Revenue: by Geography 2023
  • Figure 19. Baxter International,Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Baxter International,Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Asahi Kasei Medical Co (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Asahi Kasei Medical Co (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Ekso Bionics (United States) Revenue, Net Income and Gross profit
  • Figure 24. Ekso Bionics (United States) Revenue: by Geography 2023
  • Figure 25. Jarvik Heart (United States) Revenue, Net Income and Gross profit
  • Figure 26. Jarvik Heart (United States) Revenue: by Geography 2023
  • Figure 27. Ottobock Healthcare GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Ottobock Healthcare GmbH (Germany) Revenue: by Geography 2023
  • Figure 29. Berlin Heart GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Berlin Heart GmbH (Germany) Revenue: by Geography 2023
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 33. F Hoffman-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F Hoffman-La Roche Ltd. (Switzerland) Revenue: by Geography 2023
  • Figure 35. Gambro AB (United States) Revenue, Net Income and Gross profit
  • Figure 36. Gambro AB (United States) Revenue: by Geography 2023
  • Figure 37. Global Artificial Vital Organs: by Type USD Billion (2025-2030)
  • Figure 38. Global Artificial Vital Organs: by Application USD Billion (2025-2030)
  • Figure 39. South America Artificial Vital Organs Share (%), by Country
  • Figure 40. Asia Pacific Artificial Vital Organs Share (%), by Country
  • Figure 41. Europe Artificial Vital Organs Share (%), by Country
  • Figure 42. MEA Artificial Vital Organs Share (%), by Country
  • Figure 43. North America Artificial Vital Organs Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Edwards Lifesciences Corporation (United States)
  • Abbott Diabetes Care,Inc. (United Kingdom)
  • Baxter International,Inc. (United States)
  • Asahi Kasei Medical Co (United Kingdom)
  • Ekso Bionics (United States)
  • Jarvik Heart (United States)
  • Ottobock Healthcare GmbH (Germany)
  • Berlin Heart GmbH (Germany)
  • Boston Scientific Corporation (United States)
  • F Hoffman-La Roche Ltd. (Switzerland)
  • Gambro AB (United States)
Additional players considered in the study are as follows:
Lifenet Health (United States) , Thoratec Corporation (Canada) , World heart Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 207 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Vital Organs Market Quantitative research analysis
Global Artificial Vital Organs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Artificial Vital Organs study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Artificial Vital Organs Market is gaining popularity and expected to see strong valuation by 2030 .
According to AMA, the Global Artificial Vital Organs market is expected to see growth rate of xx%.
The Artificial Vital Organs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Artificial Vital Organs Market Report?

Have a Query? Click Here

Other Related Reports

Digital Genome Comprehensive Study by Application (Microbiology {Biological, Clinical, Industrial}, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Develop...
$ 3750
Microalbumin Test Comprehensive Study by Type (Random Urine test, 24 hour urine test, Timed urine test), Application (Hospitals, Clinics, Diagnostics Laboratories, Others), End Users (Hospitals, Clin...
$ 3650
Artificial Blood Comprehensive Study by Type (Human Blood, Synthetic Blood, Animal Blood), Application (Cardiovascular diseases, Anemia, Organ transplant, Trauma, Others), End-use (Hospitals, Clinics...
$ 3350
Cryogenic Biobanking Services Comprehensive Study by Type (Ice Machines, Freezers, Alarms And Monitoring System, Refrigerators, Cryogenic Storage Systems, Accessories), Application (Biobaking, Regene...
$ 3750
Gastritis Treatment Comprehensive Study by Type (Acid Blocking Medications, Acid Reducing Medications, Antacids, Antibiotics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, On...
$ 3650
Medical Wellness Comprehensive Study by Type (Complementary and Alternative Medicine, Beauty Care and Anti-Aging, Preventative & Personalized Medicine and Public Health, Healthy Eating, Nutrition & W...
$ 3450